
FDA Requests Removal of All Ranitidine Products from the Market
FDA Advises Consumers, Patients and Health Care Professionals After New FDA Studies Show Risk to Public Health
Read moreNews & Events
Regulatory news, updates and calendar of events related to the Industry
FDA Advises Consumers, Patients and Health Care Professionals After New FDA Studies Show Risk to Public Health
Read moreOur offices will be closed until March 31, 2020.
Read moreRegulatory Transition of Insulin and Other Biological Products
Read moreThe U.S. Food and Drug Administration announced it has authorized the marketing of two new tobacco products.
Read moreStatement from Janet Woodcock, M.D., director of FDA’s Center for Drug Evaluation and Research, on impurities found in diabetes drugs outside the U.S.
Read moreICH Updates After Singapore Assembly Meeting 16 – 20 November 2019
Read moreOrganized by Corporate Vision Magazine
Burton On Trent Staffordshire – United Kingdom
Europe at the forefront of global healthcare regulation
Read more11th Congress and Exhibition for Pharmaceutical, Biotechnology, Veterinary and Cosmetic Science and Technology.
Read more